Browse 13366 Federal Education Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Education grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| November 29th, 2022 |
FY 2023 Marine Fisheries Initiative (MARFIN) |
Department of Commerce |
| February 2nd, 2023 |
Large Scale Integrated Mapping and Molecular Profiling of Cell Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
| February 28th, 2023 |
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
National Institutes of Health |
| February 28th, 2023 |
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| November 21st, 2022 |
HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required) |
National Institutes of Health |
| April 4th, 2025 |
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 28th, 2023 |
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) |
National Institutes of Health |
| November 21st, 2022 |
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 9th, 2022 |
U.S. Nuclear Regulatory Commission Notice of Funding Opportunity Announcement (NOFO), Minority Serving Institutions Grants Program (MSIG), Scholarships, and Fellowships, Fiscal Year (FY) 2023 |
Nuclear Regulatory Commission |
| December 15th, 2022 |
FY 2023 NASA ESTABLISHED PROGRAM TO STIMULATE COMPETITIVE RESEARCH (EPSCoR) RAPID RESPONSE RESEARCH (R3) NOTICE OF FUNDING OPPORTUNITY (NOFO) |
National Aeronautics and Space Administration |
| May 7th, 2025 |
NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2025 |
NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional) |
National Institutes of Health |
| November 29th, 2022 |
NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 - Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2025 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 18th, 2022 |
Multi-Omics for Health and Disease - 'Omics Production Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2025 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) |
National Institutes of Health |
| November 18th, 2022 |
Multi-Omics for Health and Disease - Data Analysis and Coordination Center (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 18th, 2022 |
Multi-Omics for Health and Disease - Disease Study Sites (U01 Clinical Trial Optional) |
National Institutes of Health |
| November 30th, 2022 |
Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 1st, 2025 |
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) |
National Institutes of Health |
|
| October 7th, 2022 |
USAID/Ghana Strengthening Accountability in Ghana's Education System (SAGES) Systems Strengthening Activity |
Ghana USAID Accra |
| February 6th, 2024 |
NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 1st, 2025 |
Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) |
National Institutes of Health |
| November 1st, 2023 |
Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 17th, 2024 |
BRAIN Initiative: Engineering and optimization of molecular technologies for functional dissection of neural circuits (UM1 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 21st, 2022 |
Environmental influences on Child Health Outcomes (ECHO) Measurement Core (U24) Clinical Trial Not Allowed |
National Institutes of Health |
| November 21st, 2022 |
Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3) |
National Institutes of Health |
| November 21st, 2022 |
Environmental influences on Child Health Outcomes (ECHO) Data Analysis Center (U24) Clinical Trial Not Allowed |
National Institutes of Health |
| November 21st, 2022 |
Environmental influences on Child Health Outcomes (ECHO) Coordinating Center (U2C) (Clinical Trial Not Allowed) |
National Institutes of Health |
| November 21st, 2022 |
Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Cohort Study Sites for Pediatric Follow Up. Clinical Trial Not Allowed (UG3/UH3) |
National Institutes of Health |
| November 29th, 2022 |
Open Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3) |
National Institutes of Health |
| November 21st, 2022 |
Environmental influences on Child Health Outcomes (ECHO) Laboratory Core (U24) Clinical Trial Not Allowed |
National Institutes of Health |
| December 7th, 2022 |
HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Basic Experimental Studies with Humans Required) |
National Institutes of Health |
| December 7th, 2022 |
HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 7th, 2022 |
HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 22nd, 2022 |
HUDRD - HBCU Research Center of Excellence |
Department of Housing and Urban Development |
| October 20th, 2022 |
U.S. Nuclear Regulatory Commission Notice of Funding Opportunity (NOFO), the University Nuclear Leadership Program (formerly the Integrated University Program), Scholarship and Fellowship Education Grant, Distinguished |
Nuclear Regulatory Commission |
| June 20th, 2025 |
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 1st, 2025 |
Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional) |
National Institutes of Health |
| June 30th, 2023 |
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
